Investing.com - ContraFect (NASDAQ:CFRX) Corp reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
ContraFect Corp announced earnings per share of $-0.430 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.230 on revenue of $0.00.
ContraFect Corp shares are down 67% from the beginning of the year, still down 96.74% from its 52 week high of $4.54 set on June 10.
ContraFect Corp shares gained 2.71% in intra-day trade following the report.
ContraFect Corp follows other major Healthcare sector earnings this month
ContraFect Corp's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar